These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 9761532)

  • 21. [Remission of invasive sinusal and pulmonary aspergillosis with liposomal amphotericin B in a patient with chronic lymphatic leukemia following failure with conventional amphotericin].
    Palacio C; Acebedo G; López A; Jodar JM
    Sangre (Barc); 1994 Oct; 39(5):389-92. PubMed ID: 7754445
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Liposomal amphotericin B can safely be administered in paediatric outpatients with cancer for the primary or secondary prevention of invasive aspergillosis.
    Simon A; Bode U; Maul M; Fleischhack G
    Acta Haematol; 2007; 118(2):68-9. PubMed ID: 17538246
    [No Abstract]   [Full Text] [Related]  

  • 23. Successful treatment of invasive pulmonary aspergillosis in an immunocompetent host.
    Polat G; Urpek G; Yilmaz U; Büyükşirin M; Karadağ Polat S; Uluer S; Tibet G
    Respirology; 2005 Jun; 10(3):393-5. PubMed ID: 15955156
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Liposomal amphotericin B therapy of murine histoplasmosis.
    Graybill JR; Bocanegra R
    Antimicrob Agents Chemother; 1995 Aug; 39(8):1885-7. PubMed ID: 7486941
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intraventricular amphotericin for absidiomycosis in an immunocompetent child.
    Tsung LL; Zhu XL; Chu WC; Sun DT; Cheung KL; Leung TF
    Hong Kong Med J; 2010 Apr; 16(2):137-40. PubMed ID: 20354249
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Successful treatment of invasive pulmonary aspergillosis by transbronchial injection of urinary trypsin inhibitor and amphotericin B.
    Harashima S; Tsukamoto H; Nishizaka H; Otsuka J; Hiriuchi T
    Acta Haematol; 2003; 109(3):156-7. PubMed ID: 12747372
    [No Abstract]   [Full Text] [Related]  

  • 27. Liposomal amphotericin B (AmBisome) efficacy in confirmed invasive aspergillosis and other filamentous fungal infections in immunocompromised hosts: a pooled analysis.
    Cordonnier C; Bresnik M; Ebrahimi R
    Mycoses; 2007 May; 50(3):205-9. PubMed ID: 17472618
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Liposomal amphotericin B. Therapeutic use in the management of fungal infections and visceral leishmaniasis.
    Coukell AJ; Brogden RN
    Drugs; 1998 Apr; 55(4):585-612. PubMed ID: 9561346
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cerebellar aspergillosis: case report and literature review.
    Erdogan E; Beyzadeoglu M; Arpaci F; Celasun B
    Neurosurgery; 2002 Apr; 50(4):874-6; discussion 876-7. PubMed ID: 11904042
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of invasive pulmonary aspergillosis in severely neutropenic children with malignant disorders using liposomal amphotericin B (AmBisome), granulocyte colony-stimulating factor, and surgery: report of five cases.
    Dornbusch HJ; Urban CE; Pinter H; Ginter G; Fotter R; Becker H; Miorini T; Berghold C
    Pediatr Hematol Oncol; 1995; 12(6):577-86. PubMed ID: 8589003
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Massive intracerebral aspergillosis responding to combination high dose liposomal amphotericin B and cytokine therapy without surgery.
    Ellis M; Watson R; McNabb A; Lukic ML; Nork M
    J Med Microbiol; 2002 Jan; 51(1):70-75. PubMed ID: 11800475
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Treatment of pulmonary aspergilloma. Clinical review].
    Martínez J; Márquez M; Sola O; Arés J; Grarau J
    Enferm Infecc Microbiol Clin; 2000 Oct; 18(8):413-5. PubMed ID: 11153205
    [No Abstract]   [Full Text] [Related]  

  • 33. Is liposomal amphotericin B (ambisome) an effective prophylaxis of mycotic infections after liver transplantation?
    Braun F; Rüchel R; Lorf T; Canelo R; Müller A; Sattler B; Ringe B
    Transplant Proc; 1998 Jun; 30(4):1481-3. PubMed ID: 9636602
    [No Abstract]   [Full Text] [Related]  

  • 34. Successful treatment of disseminated central nervous aspergillosis in a patient with acute myeloblastic leukemia.
    Mahlknecht U; von Lintig F; Mertelsmann R; Lindemann A; Lübbert M
    Leuk Lymphoma; 1997 Sep; 27(1-2):191-4. PubMed ID: 9373212
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Cerebral aspergillosis in an HIV-infected patient: unsuccessful outcome despite combined antifungal therapy. ].
    Gasch O; Fernández N; Ayats J; Santin M
    Enferm Infecc Microbiol Clin; 2009 Mar; 27(3):193-4. PubMed ID: 19306722
    [No Abstract]   [Full Text] [Related]  

  • 36. Therapeutic and hemolytic evaluation of in-situ liposomal preparation containing amphotericin - beta complexed with different chemically modified beta - cyclodextrins.
    Chakraborty KK; Naik SR
    J Pharm Pharm Sci; 2003; 6(2):231-7. PubMed ID: 12935435
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Candida peritonitis treated with liposomal amphotericin B.
    Ng SY; Morgan M
    Postgrad Med J; 1996 Oct; 72(852):636-7. PubMed ID: 8977956
    [No Abstract]   [Full Text] [Related]  

  • 38. [A case of cerebral aspergillosis associated with induction chemotherapy for acute lymphoblastic leukemia].
    Okamoto K; Kuroiwa A; Yokoyama Y; Kamoda F; Kinumaki H; Shitara N
    No To Shinkei; 1996 Nov; 48(11):1047-51. PubMed ID: 8951897
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Focus on fungal infections.
    MacDougall DS
    J Int Assoc Physicians AIDS Care; 1997 Jul; 3(7):27-32. PubMed ID: 11364470
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antimycotic therapy with liposomal amphotericin-B for patients undergoing bone marrow or peripheral blood stem cell transplantation.
    Krüger W; Stockschläder M; Sobottka I; Betker R; De Wit M; Kröger N; Grimm J; Arland M; Fiedler W; Erttmann R; Zander AR
    Leuk Lymphoma; 1997 Feb; 24(5-6):491-9. PubMed ID: 9086439
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.